R. André Raposo

R. André Raposo is the Director of Innovation at Oxford Biomedica, with a background in Immunology and Biochemistry. Previously, at GSK, R. André excelled as a Senior Scientist in the field of Cell & Gene Therapy Platform CMC. With experience as a Research Scientist at George Washington University and a Postdoctoral Scholar at UCSF, their expertise extends to mechanisms of HIV-1 persistence and intrinsic resistance factors. With a Doctor of Philosophy degree from the University of Oxford, R. André is a driven and accomplished individual in the field of biomedicine.